deltatrials
Completed NCT00393341

Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer

Sponsor: Breast Cancer Research Foundation

Conditions Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage IV
Interventions Blood Draw
Updated 10 times since 2017 Last updated: Aug 27, 2015 Started: Oct 31, 2006 Primary completion: May 31, 2009 Completion: Aug 31, 2009

Listed as NCT00393341, this observational or N/A phase trial focuses on Breast Cancer Stage I and Breast Cancer Stage II and remains completed. Sponsored by Breast Cancer Research Foundation, it has been updated 10 times since 2006, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 5 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Completed

  2. May 2018 — Jun 2018 [monthly]

    Completed

  3. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  4. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  5. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Breast Cancer Research Foundation
  • Indiana University School of Medicine
Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Indianapolis, United States